You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 278 No. 21, December 3, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cost-effectiveness of the Clinical Practice Recommendations in the AHCPR Guideline for Smoking Cessation

Jerry Cromwell, PhD; William J. Bartosch, MPA; Michael C. Fiore, MD, MPH; Victor Hasselblad, PhD; Timothy Baker, PhD

JAMA. 1997;278(21):1759-1766.


Abstract

Context.
—The Agency for Health Care Policy and Research (AHCPR) published the Smoking Cessation: Clinical Practice Guideline in 1996. Based on the results of meta-analyses and expert opinion, the guideline identifies efficacious interventions for primary care clinicians and smoking cessation specialty providers.

Objective.
—To determine the cost-effectiveness of clinical recommendations in AHCPR's guideline.

Design.
—The guideline's 15 recommended smoking cessation interventions were analyzed to determine their relative cost-effectiveness. Then, using decision probabilities, the interventions were combined into a global model of the guideline's overall cost-effectiveness.

Patients.
—The analysis assumes that primary care clinicians screen all presenting adults for smoking status and advise and motivate all smokers to quit during the course of a routine office visit or hospitalization. Smoking cessation interventions are provided to 75% of US smokers 18 years and older who are assumed to be willing to make a quit attempt during a year's time.

Intervention.
—Three counseling interventions for primary care clinicians and 2 counseling interventions for smoking cessation specialists were modeled with and without transdermal nicotine and nicotine gum.

Main Outcome Measure.
—Cost (1995 dollars) per life-year or quality-adjusted life-year (QALY) saved, at a discount of 3%.

Results.
—The guideline would cost $6.3 billion to implement in its first year. As a result, society could expect to gain 1.7 million new quitters at an average cost of $3779 per quitter, $2587 per life-year saved, and $1915 for every QALY saved. Costs per QALY saved ranged from $1108 to $4542, with more intensive interventions being more cost-effective. Group intensive cessation counseling exhibited the lowest cost per QALY saved, but only 5% of smokers appear willing to undertake this type of intervention.

Conclusions.
—Compared with other preventive interventions, smoking cessation is extremely cost-effective. The more intensive the intervention, the lower the cost per QALY saved, which suggests that greater spending on interventions yields more net benefit. While all these clinically delivered interventions seem a reasonable societal investment, those involving more intensive counseling and the nicotine patch as adjuvant therapy are particularly meritorious.



Author Affiliations

From Health Economics Research, Inc, Waltham, Mass (Dr Cromwell and Mr Bartosch); the Center for Tobacco Research and Intervention (Drs Fiore and Baker), Section of General Internal Medicine, Department of Medicine (Drs Fiore and Baker), Comprehensive Cancer Center (Dr Fiore), and Department of Psychology (Dr Baker), University of Wisconsin Medical School, Madison; and the Center for Health Policy Research and Education, Duke University, Durham, NC (Dr Hasselblad).


Footnotes

Since publication of the AHCPR Smoking Cessation Clinical Practice Guideline in April 1996, Dr Fiore has done consulting, received funding for clinical research studies, and/or spoken on behalf of GlaxoWellcome, SmithKline Beecham, and McNeil pharmaceutical companies. Dr Baker has done consulting, research, and/or speaking for SmithKline Beecham pharmaceutical company. Prior to 1994 (when work on the Guideline began), Drs Baker and Fiore had worked on clinical research studies funded in part by ALZA Corp, CIBA-Geigy Corp, Elan Pharmaceutical, Lederle Laboratories, Glaxo Wellcome, SmithKline Beecham, and Hoechst Marion Rousel Inc. Prior to 1994, Dr. Fiore had received honoraria for educational activities from CIBA-Geigy, Elan, Lederle, Marion Merrell Dow Inc, and Parke-Davis.

The statements contained in this article are solely those of the authors and do not necessarily reflect the views or opinions of the Agency for Health Care Policy and Research.

Reprints: Jerry Cromwell, PhD, Health Economics Research, Inc, 300 Fifth Ave, Sixth Floor, Waltham, MA 02154 (e-mail: jcromwell@her-cher.org).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Cost-effectiveness of the AHCPR Guidelines for Smoking
Ivana T. Croghan, Kenneth P. Offord, Christi A. Patten, Richard D. Hurt, Kevin M. Fosnocht, Jerry Cromwell, William J. Bartosch, Michael C. Fiore, Timothy Baker, and Victor Hasselblad
JAMA. 1998;279(11):836-837.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Do the correlates of smoking cessation counseling differ across health professional groups?
Tremblay et al.
Nicotine Tob Res 2009;11:1330-1338.
ABSTRACT | FULL TEXT  

Tobacco Use: A Pediatric Disease
Committee on Environmental Health, Committee on Su
Pediatrics 2009;124:1474-1487.
ABSTRACT | FULL TEXT  

Prevention: Russell Responds
Russell
Health Aff (Millwood) 2009;28:1556-1556.
FULL TEXT  

Responses to Online GSTM1 Genetic Test Results among Smokers Related to Patients with Lung Cancer: A Pilot Study
Sanderson et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:1953-1961.
ABSTRACT | FULL TEXT  

Effect of Smoking Cessation Advice on Cardiovascular Disease
Eddy et al.
American Journal of Medical Quality 2009;24:241-249.
ABSTRACT  

Smoking and Weight Change After New Health Diagnoses in Older Adults
Keenan
Arch Intern Med 2009;169:237-242.
ABSTRACT | FULL TEXT  

A Randomized Trial of a Pay-for-Performance Program Targeting Clinician Referral to a State Tobacco Quitline
An et al.
Arch Intern Med 2008;168:1993-1999.
ABSTRACT | FULL TEXT  

Review: Pharmacotherapy for smoking cessation
Carrozzi et al.
Ther Adv Respir Dis 2008;2:301-317.
ABSTRACT  

Using radon risk to motivate smoking reduction II: randomized evaluation of brief telephone counseling and a targeted video
Lichtenstein et al.
Health Educ Res 2008;23:191-201.
ABSTRACT | FULL TEXT  

Value of Patient Time Invested in the Colonoscopy Screening Process: Time Requirements for Colonoscopy Study
Jonas et al.
Med Decis Making 2008;28:56-65.
ABSTRACT  

Cost effectiveness of the Oregon quitline "free patch initiative"
Fellows et al.
Tobacco Control 2007;16:i47-i52.
ABSTRACT | FULL TEXT  

Tobacco quitlines: looking back and looking ahead
Anderson and Zhu
Tobacco Control 2007;16:i81-i86.
ABSTRACT | FULL TEXT  

A review of the cost-effectiveness of face-to-face behavioural interventions for smoking, physical activity, diet and alcohol
Gordon et al.
Chronic Illness 2007;3:101-129.
ABSTRACT  

Economic Analysis of NCIC CTG JBR.10: A Randomized Trial of Adjuvant Vinorelbine Plus Cisplatin Compared With Observation in Early Stage Non-Small-Cell Lung Cancer--A Report of the Working Group on Economic Analysis, and the Lung Disease Site Group, National Cancer Institute of Canada Clinical Trials Group
Ng et al.
JCO 2007;25:2256-2261.
ABSTRACT | FULL TEXT  

Lifestyle Medicine Strategies for Risk Factor Reduction, Prevention, and Treatment of Coronary Heart Disease: Part II
Rippe et al.
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2007;1:79-90.
ABSTRACT  

Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy
Tonnesen et al.
Eur Respir J 2007;29:390-417.
ABSTRACT | FULL TEXT  

Risk Factors for Mortality in Middle-aged Women
Tice et al.
Arch Intern Med 2006;166:2469-2477.
ABSTRACT | FULL TEXT  

Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy.
An et al.
Tobacco Control 2006;15:286-293.
ABSTRACT | FULL TEXT  

Progress and opportunities in tobacco control.
Cokkinides et al.
CA Cancer J Clin 2006;56:135-142.
ABSTRACT | FULL TEXT  

Benefits of telephone care over primary care for smoking cessation: a randomized trial.
An et al.
Arch Intern Med 2006;166:536-542.
ABSTRACT | FULL TEXT  

A Randomized Controlled Trial of Financial Incentives for Smoking Cessation
Volpp et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:12-18.
ABSTRACT | FULL TEXT  

Older Adults' and Case Managers' Perceptions of Smoking and Smoking Cessation
Schmitt et al.
J Aging Health 2005;17:717-733.
ABSTRACT  

Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death
Hubbard et al.
Tobacco Control 2005;14:416-421.
ABSTRACT | FULL TEXT  

Evaluation of an Adolescent Smoking-Cessation Media Campaign: GottaQuit.com
Klein et al.
Pediatrics 2005;116:950-956.
ABSTRACT | FULL TEXT  

The health benefits of smoking cessation for adult smokers and for pregnant women in Taiwan
Wen et al.
Tobacco Control 2005;14:i56-i61.
ABSTRACT | FULL TEXT  

Cost effectiveness of a community based research project to help women quit smoking
Secker-Walker et al.
Tobacco Control 2005;14:37-42.
ABSTRACT | FULL TEXT  

Treatment of Tobacco Use in an Inpatient Psychiatric Setting
Prochaska et al.
Psychiatr. Serv. 2004;55:1265-1270.
ABSTRACT | FULL TEXT  

Effectiveness of Implementing the Agency for Healthcare Research and Quality Smoking Cessation Clinical Practice Guideline: A Randomized, Controlled Trial
Katz et al.
JNCI J Natl Cancer Inst 2004;96:594-603.
ABSTRACT | FULL TEXT  

Economics of smoking cessation
Parrott and Godfrey
BMJ 2004;328:947-949.
FULL TEXT  

Telephone assistance for smoking cessation: one year cost effectiveness estimations
McAlister et al.
Tobacco Control 2004;13:85-86.
ABSTRACT | FULL TEXT  

Preventing 3 Million Premature Deaths and Helping 5 Million Smokers Quit: A National Action Plan for Tobacco Cessation
Fiore et al.
AJPH 2004;94:205-210.
ABSTRACT | FULL TEXT  

Diabetic Patients Who Smoke: Are They Different?
Solberg et al.
Ann Fam Med 2004;2:26-32.
ABSTRACT | FULL TEXT  

Cost-effectiveness of Screening for Lung Cancer--Reply
Mahadevia and Powe
JAMA 2003;289:2358-2359.
FULL TEXT  

Oral tobacco cessation with UK resident Bangladeshi women: a community pilot investigation
Croucher et al.
Health Educ Res 2003;18:216-223.
ABSTRACT | FULL TEXT  

References
Circulation 2002;106:3373-3421.
FULL TEXT  

Cost-Effectiveness of Pharmacological Interventions for Smoking Cessation: a Literature Review and a Decision Analytic Analysis
Song et al.
Med Decis Making 2002;22:S26-S37.
ABSTRACT  

Optimal Allocation of Resources Across Four Interventions for Type 2 Diabetes
Earnshaw et al.
Med Decis Making 2002;22:S80-S91.
ABSTRACT  

Task Force #2--the cost of prevention: can we afford it? Can we afford not to do it?
Krumholz et al.
J Am Coll Cardiol 2002;40:603-615.
FULL TEXT  

Treatment of Tobacco Use and Dependence
Rigotti
NEJM 2002;346:506-512.
FULL TEXT  

A Simulation Model of Policies Directed at Treating Tobacco Use and Dependence
Levy and Friend
Med Decis Making 2002;22:6-17.
ABSTRACT  

The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost
Goldman et al.
J Am Coll Cardiol 2001;38:1012-1017.
ABSTRACT | FULL TEXT  

Coverage of Smoking Cessation Treatment by Union Health and Welfare Funds
Barbeau et al.
AJPH 2001;91:1412-1415.
ABSTRACT | FULL TEXT  

Cost-effectiveness of a School-Based Tobacco-Use Prevention Program
Wang et al.
Arch Pediatr Adolesc Med 2001;155:1043-1050.
ABSTRACT | FULL TEXT  

Treating Nicotine Addiction . Not a Medical Problem?
BRITTON et al.
Am. J. Respir. Crit. Care Med. 2001;164:13-15.
FULL TEXT  

Impact of smoking habit on medical care use and its costs: a prospective observation of National Health Insurance beneficiaries in Japan
Izumi et al.
Int J Epidemiol 2001;30:616-621.
ABSTRACT | FULL TEXT  

Quality improvement and accountability in the treatment of tobacco dependence: the need for a national training and certification programme
DAVIS et al.
Tobacco Control 2000;9:355-358.
FULL TEXT  

A survey of managed care strategies for pregnant smokers
Barker et al.
Tobacco Control 2000;9:46i-50.
ABSTRACT | FULL TEXT  

A 36-Year-Old Woman Who Smokes Cigarettes
Rigotti
JAMA 2000;284:741-749.
FULL TEXT  

A Clinical Practice Guideline for Treating Tobacco Use and Dependence: A US Public Health Service Report
The Tobacco Use and Dependence Clinical Practice G
JAMA 2000;283:3244-3254.
ABSTRACT | FULL TEXT  

Cigarette consumption and sales of nicotine replacement products
Hu et al.
Tobacco Control 2000;9 :ii60-ii63.
ABSTRACT | FULL TEXT  

Cost-effectiveness of the Lower Treatment Goal (of JNC VI) for Diabetic Hypertensive Patients
Elliott et al.
Arch Intern Med 2000;160:1277-1283.
ABSTRACT | FULL TEXT  

New Developments in Smoking Cessation
Prochazka
Chest 2000;117 :169S-175S.
ABSTRACT | FULL TEXT  

Investing in youth tobacco control: a review of smoking prevention and control strategies
Lantz et al.
Tobacco Control 2000;9:47-63.
ABSTRACT | FULL TEXT  

Building a comprehensive, evidence based tobacco treatment system in managed care
BARKER
Tobacco Control 2000;9:i1-1.
FULL TEXT  

Implementing tobacco interventions in the real world of managed care
Hollis et al.
Tobacco Control 2000;9:i18-24.
FULL TEXT  

Designing tobacco control systems and cessation benefits in managed care: skill building workshop
Carlson et al.
Tobacco Control 2000;9:i25-29.
FULL TEXT  

Incentivising, facilitating, and implementing an office tobacco cessation system
Solberg
Tobacco Control 2000;9:i37-41.
FULL TEXT  

Cost Utility Analysis of Radiographic Screening for an Orbital Foreign Body before MR Imaging
Seidenwurm et al.
Am. J. Neuroradiol. 2000;21:426-433.
ABSTRACT | FULL TEXT  

Guidelines in Pulmonary Medicine: A 25-Year Profile
Hackner et al.
Chest 1999;116:1046-1062.
ABSTRACT | FULL TEXT  

Four beliefs that may impede progress in the treatment of smoking
Hughes
Tobacco Control 1999;8:323-326.
ABSTRACT | FULL TEXT  

Adding Behavioral Therapy to Medication for Smoking Cessation
Deagle III et al.
JAMA 1999;281:1983-1985.
FULL TEXT  

Prevention of a First Stroke: A Review of Guidelines and a Multidisciplinary Consensus Statement From the National Stroke Association
Gorelick et al.
JAMA 1999;281:1112-1120.
ABSTRACT | FULL TEXT  

Perceived Risks of Heart Disease and Cancer Among Cigarette Smokers
Ayanian and Cleary
JAMA 1999;281:1019-1021.
ABSTRACT | FULL TEXT  

The Cost Effectiveness of Strategies for the Treatment of Intestinal Parasites in Immigrants
Muennig et al.
NEJM 1999;340:773-779.
ABSTRACT | FULL TEXT  

Prevention and Medicare Costs
Russell
NEJM 1998;339:1158-1160.
FULL TEXT  

Use and Cost Effectiveness of Smoking-Cessation Services under Four Insurance Plans in a Health Maintenance Organization
Curry et al.
NEJM 1998;339:673-679.
ABSTRACT | FULL TEXT  

Cost-effectiveness of the AHCPR Guidelines for Smoking
Croghan et al.
JAMA 1998;279:836-837.
FULL TEXT  

Reinventing American Tobacco Policy: Sounding the Medical Community's Voice
Koop et al.
JAMA 1998;279:550-552.
FULL TEXT  

Smoking: It Pays to Quit
JWatch Women's Health 1998;1998:19-19.
FULL TEXT  

Patient Smoking Cessation Advice by Health Care Providers: The Role of Ethnicity, Socioeconomic Status, and Health
Houston et al.
AJPH 2005;95:1056-1061.
ABSTRACT | FULL TEXT  

Free Nicotine Replacement Therapy Programs vs Implementing Smoke-Free Workplaces: A Cost-Effectiveness Comparison
Ong and Glantz
AJPH 2005;95:969-975.
ABSTRACT | FULL TEXT  

The Role of Research in International Tobacco Control
Warner
AJPH 2005;95:976-984.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.